AGI-14100
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Product Specifications
CAS Number
1448346-43-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
599.96
Molecular Formula
C29H22ClF4N5O3
Notes
Research use only, not for human use.
Receptor
Dehydrogenase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS749640-01 48 Well
Bovine Endoplasmic Reticulum To Nucleus Signalling 1 ELISA Kit
Sign In for Pricing
View Details MBS749640-02 96 Well
Bovine Endoplasmic Reticulum To Nucleus Signalling 1 ELISA Kit
Sign In for Pricing
View Details MBS749640-03 5x 96 Well
Bovine Endoplasmic Reticulum To Nucleus Signalling 1 ELISA Kit
Sign In for Pricing
View Details MBS749640-04 10x 96 Well
Bovine Endoplasmic Reticulum To Nucleus Signalling 1 ELISA Kit
Sign In for Pricing
View Details 
BMB18703-01 50 mg
2- (4-Aminopiperidin-1-yl) -1- (pyrrolidin-1-yl) ethan-1-one
Sign In for Pricing
View Details BMB18703-02 0.5 g
2- (4-Aminopiperidin-1-yl) -1- (pyrrolidin-1-yl) ethan-1-one
Sign In for Pricing
View Details